A complaint alleging Pradaxa side effects was filed on June 21, 2012, in New Jersey by Richard Armiger. On August 17, 2012, the complaint was transferred to the multidistrict litigation (MDL) against Pradaxa in the U.S. District Court, Southern District of Illinois. Armiger is suing... Read More

One of the new Pradaxa lawsuits filed in the Northern District of Mississippi on September 6, 2012, was transferred to the federal multidistrict litigation (MDL) in the Southern District of Illinois on September 21. The Honorable Judge David R. Herndon is overseeing the case and... Read More

Attorneys for plaintiff John Fontana, a resident of New Jersey, filed a lawsuit against Pradaxa manufacturer Boehringer Ingelheim on September 13, 2012 in the U.S. District Court for the Northern District of California. As with most other Pradaxa lawsuits, Fontana's complaint states that he suffered... Read More

In a lawsuit recently added to the Pradaxa multidistrict litigation, plaintiff John Colletta of Illinois states that after taking the anticoagulant drug for less than six months, he suffered an episode of Pradaxa internal bleeding that resulted in his being hospitalized for 10 days. The... Read More

Pradaxa litigation continues to grow as more patients who have suffered bleeding from the anticoagulant file lawsuits against Boehringer Ingelheim Pharmaceuticals, the drug's manufacturer. But despite the lawsuits, there has been no announcement of a recall. Bleeding risk from Pradaxa Pradaxa was approved by the... Read More

On September 10, 2012, a new lawsuit seeking compensation for Pradaxa injuries was filed against manufacturer Boehringer Ingelheim was filed in the U.S. District Court of Pennsylvania. In the filing, the plaintiff, 69-year-old Mary Ann Krszal claims that she was prescribed the anticoagulant Pradaxa (dabigatran)... Read More

On September 12, 2012, Judge David R. Herndon issued a stay of all pending motions in the Pradaxa MDL until further notice, in order to take time to establish the structure of the proceedings to come, and to enable interested Pradaxa lawyers to apply for... Read More

Some medical experts believe that the Food and Drug Administration may have rushed the approval of the anticoagulant drug Pradaxa without fully evaluating the safety of the medication. Two drug safety experts assert this claim in the Journal of the American Medical Association, in an... Read More